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Abstract Tyrosine hydroxylase (TH), which converts L-tyrosine
to L-3,4-dihydroxyphenylalanine, is a rate-limiting enzyme in the
biosynthesis of catecholamines; its activity is regulated by the
feedback inhibition of the catecholamine products including
dopamine. To rationalize the significant role of the N-terminal
sequence Arg37-Arg38 of human TH type 1 (hTH1) in determin-
ing the efficiency of feedback inhibition, we produced mutants of
which the positively charged Arg37-Arg38 site was replaced by
electrically neutral Gly and/or negatively charged Glu and
analyzed the degree of inhibition of these mutant enzymes by
dopamine. The replacement of Arg by Gly reduced the inhibitory
effect of dopamine on the catalytic activity measured in the basic
pH range and the replacement of Arg by Glu was enough to
abolish the inhibitory effect, although these mutations brought no
significant changes to the circular dichroism spectrum. The
prediction of the secondary structure of N-terminal residues 1^60
by computer software specified the location of the Arg37-Arg38
sequence in the turn intervening between the two K-helices
(residues 16^29 and residues 41^59). These results suggest that
the positive charge of the amino acid residues at positions 37 and
38 is one of the main factors that maintains the characteristic of
the turn and is responsible for the enzyme inhibition by
dopamine.
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1. Introduction
Tyrosine hydroxylase (TH; tyrosine 3-monooxygenase; L-
tyrosine, tetrahydropterin: oxygen oxidoreductase (3-hydrox-
ylating); EC 1.14.16.2) is the rate-limiting enzyme in the bio-
synthesis of catecholamines [1] and catalyzes the conversion of
L-tyrosine to L-3,4-dihydroxyphenylalanine (L-dopa) [2]. TH
consists of a catalytic domain and a regulatory domain [3].
The catalytic domain is located at the C-terminal two-thirds
of the molecule and binds the substrates (L-tyrosine and mo-
lecular oxygen) and the cofactor (6R-tetrahydrobiopterin;
6RBPH4). In contrast, the important roles controlling the
enzyme activity have been assigned to the N-terminal end as
the regulatory domain.
The catalytic activity of TH is inhibited by the end-product
catecholamines [2], and the phosphorylation of Ser residues in
the N-terminus relieves the catecholamine-mediated inhibition
[4]. Many observations have been reported that indicate the
importance of residues 30^40 in the N-terminus in this inhib-
ition, and Arg37-Arg38 was found to be a key sequence for
dopamine to exert its inhibitory e¡ect on the catalytic activity
of human TH type 1 (hTH1) [5,6]. The phosphorylation of
Ser31 and Ser40 among three di¡erent phosphorylation sites in
the N-terminus enhanced the catalytic activity of TH [7,8].
hTH3, which possesses an additional 27 amino acids between
the Met30 and Ser31 of hTH1, was about ¢ve times more
active than hTH1 [9]. However, all these observations con-
cerning the N-terminus of hTH1 remain to be explained. In
this study, from among the issues maintained above, we ad-
dressed the phenomenon of dopamine inhibition of hTH1
catalytic activity and sought to rationalize the critical role
of the sequence Arg37-Arg38 underlying the dopamine-induced
inhibition.
In the study described herein, at ¢rst we analyzed the role
of the sequence Arg37-Arg38 in dopamine-mediated inhibition
by using hTH1 mutants in which Arg37 and/or Arg38 was
replaced by Gly and/or Glu to modulate their electrical
charges, and, next, we predicted the secondary structure of
N-terminal residues 1^60 with the assistance of computer soft-
ware. Finally, we discussed the importance of the sequence
Arg37-Arg38 for the residues 30^40 in the N-terminus of
hTH1.
2. Materials and methods
2.1. Materials
Escherichia coli strain BL21(DE3) (F, omp T, r3, m3) was pur-
chased from Novagen (Madison, WI, USA). pKF18k vector was
from Takara (Kyoto, Japan). Restriction enzymes were obtained
from New England BioLabs (Beverly, MA, USA). 6RBPH4 was syn-
thesized as previously described [10]. All other reagents used in this
study were purchased from Sigma (St. Louis, MO, USA), Boehringer-
Mannheim (Mannheim, Germany), Merck (Darmstadt, Germany),
Wako (Osaka, Japan) and Nacalai (Kyoto, Japan), and were of ana-
lytical grade.
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2.2. Site-directed mutagenesis
The full-length hTH1 cDNA cloned into pET3c vector [11] was
digested with NdeI and BamHI, and the resulting hTH1 cDNA frag-
ment was inserted into the pKF18k vector. Site-directed mutagenesis
was performed with the pKF18k vector containing hTH1 cDNA as a
template by the oligonucleotide-directed dual amber method [12] us-
ing a mutagenesis kit (Takara). The mutants with replacement of
Arg37-Arg38 by Gly or Glu are referred to as RR-RG for Arg37-
Gly38, RR-GR for Gly37-Arg38, RR-GG for Gly37-Gly38, and RR-
EE for Glu37-Glu38. The mutagenic primers used were as follows:
5P-CTC-GAT-GAG-GCT-CTG-CCT-GCC-CCC-AAT-GAA-CCG-
CGG for RR-GR, 5P-CTC-GAT-GAG-GCT-CTG-CCC-GCG-CCC-
AAT-GAA-CCG-CGG for RR-RG, 5P-CTC-GAT-GAG-GCT-CTG-
CCC-GCC-CCC-AAT-GAA-CCG-CGG for RR-GG and 5P-CTC-
GAT-GAG-GCT-CTG-CTC-CTC-CCC-AAT-GAA-CCG-CGG for
RR-EE. DNA sequences of positive mutant clones were con¢rmed
by using a model 373A DNA Sequencing System (Applied Biosys-
tems, Foster City, CA, USA). The mutated hTH1 cDNA in the
pKF18k vector was digested with NdeI and BamHI, and the resulting
hTH1 cDNA was inserted by ligation into the pET3c vector. The
plasmid DNA was used to transform E. coli BL21(DE3).
2.3. Expression and puri¢cation of enzymes
According to the method described by Nasrin et al., the expression
of the hTH1 molecule in E. coli strain BL21(DE3) was initiated in
Luria-Bertani medium containing ampicillin and ferrous ammonium
sulfate by the addition of isopropyl-L-D-thiogalactopyranoside [13].
The puri¢cation was performed at 4‡C according to the method out-
lined by Oka [14]. Solid ammonium sulfate was added to the super-
natant of the cell lysates of E. coli BL21(DE3) to 20% saturation, and
the mixture was stirred for 1 h. The precipitate was removed by
centrifugation at 15 000Ug for 15 min. Then, solid ammonium sulfate
was added to the supernatant to 40% saturation, and the mixture was
stirred for another 1 h. The precipitate was collected by centrifugation
at 15 000Ug for 15 min and dissolved in 20 mM Tris^HCl bu¡er (pH
7.3) containing 8% sucrose and 1 mM dithiothreitol (T-bu¡er). Next,
the solution was passed through a Superose 6HR 10/30 column
(Amersham Pharmacia Bioteck, Uppsala, Sweden) equilibrated with
T-bu¡er. The active fraction was applied to a heparin-Sepharose col-
umn (Amersham Pharmacia Bioteck) equilibrated with T-bu¡er, and
then hTH1 protein was eluted with a gradient of KCl in T-bu¡er (0^
0.4 M).
2.4. Assay of catalytic activity of enzymes
The catalytic activity of the mutant enzymes was assayed according
to the method by Nagatsu et al. [15] with minor modi¢cations. The
enzymes were preincubated at 30‡C for 20 min in 25 Wl of T-bu¡er
containing with various doses of dopamine. The concentration of each
enzyme was 16 Wg/ml in the preincubation solution. The assay was
started by the addition of 175 Wl of the mixture of 57 mM HEPES,
114 mM L-mercaptoethanol, 0.23 mg/ml catalase, 0.057 mM L-tyro-
sine and 0.23 mM 6RBPH4 to the preincubation solution, and then
the sample was incubated at 37‡C for 10 min in the air. The resulting
L-dopa was isolated by use of a high performance liquid chromatog-
raphy apparatus (Shimadzu, Kyoto, Japan) equipped with a Nucleosil
7C18 column (4.6 in diameterU250 mm) (GL Sciences, Tokyo, Japan)
equilibrated with 0.1 M sodium phosphate bu¡er (pH 3.5) containing
1% methanol and 4 WM EDTA, and measured with an electrochem-
ical detector ECD-100 (EiCOM, Kyoto, Japan). The assay was linear
for at least 15 min at the enzyme concentration used.
2.5. Prediction of the secondary structure
The secondary structure of wild-type hTH1 was predicted from the
amino acid sequence according to both the method of Chou^Fasman
(CF-Pred) [16] and that of Robson^Garnier (GOR-Pred) [17] on a
SPARC workstation with a Sun operating system (Sun Microsystems,
Palo Alto, CA, USA) using the Sequence Analysis Software Package
(Genetics Computer Group, Madison, WI, USA) [18]. The secondary
structural predictions were also made according to a modi¢ed method
of Robson^Garnier (modi¢ed GOR) [19], to a method using a pro¢le-
fed neural network system from Heidelberg (PHD) [20^24], and to
that using the 3D-1D compatibility algorithm (3D-1D) [25,26].
2.6. Circular dichroism (CD) spectrometry
CD spectra of the wild-type hTH1 and four mutants were recorded
at 25‡C by using a J-720 CD spectropolarimeter (JASCO, Tokyo,
Japan) equipped with a 0.1 cm cell.
2.7. Other methods
Protein concentration was measured with the Bio-Rad Protein As-
say kit (Hercules, CA, USA) with bovine serum albumin as a stand-
ard. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed with 12.5% gel [27] and then, the proteins were
stained with Coomassie brilliant blue R-250.
3. Results
3.1. Prediction of the secondary structure
Using ¢ve di¡erent methods, we predicted the secondary
structure of the N-terminus of hTH1 (residues 1^60). There
Fig. 1. Prediction of the secondary structure of the N-terminal 1^60 amino acids of hTH1. Prediction methods used were as follows: CF-Pred:
the method of Chou^Fasman, GOR-Pred: the method of Robson^Garnier, Modi¢ed GOR: a modi¢ed method of Robson^Garnier, PHD: a
method using a pro¢le-fed neural network system from Heidelberg, 3D-1D: a method using the 3D-1D compatibility algorithm. Computer soft-
ware used in this study is listed in the text. Open triangles indicate sites for phosphorylation by kinases; Ser19 : type II calcium/calmodulin-de-
pendent protein kinase (Ca/CAM-PKII), Ser31 : mitogen-activated protein kinases, Ser40 : cyclic AMP-dependent protein kinase, protein kinase
C and even Ca/CaM-PKII. Closed triangles indicate the speci¢c portion critical for the dopamine-induced inhibition.
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was no signi¢cant di¡erence among the ¢ve predictions of the
secondary structure, as shown in Fig. 1. Residues 1^60 were
supposed to be composed of two K-helices connected by a
turn. The ¢rst K-helix corresponded to approximately amino
acid residues 16^29, and the second K-helix to around amino
acid residues 41^59.
3.2. Puri¢cation and TH activity
The wild-type enzyme and four mutants were puri¢ed by
the following three steps: ammonium sulfate precipitation,
gel-permeation with Superose 6HR 10/30 column, and hepa-
rin-Sepharose column chromatography. The elution of wild-
type and the mutants from heparin-Sepharose with a gradient
of KCl depended on the charge of amino acids at positions 37
and 38; wild-type, RR-RG, RR-GR, RR-GG and RR-EE
eluted at the concentration of 0.36, 0.35, 0.35, 0.31 and 0.28
M KCl, respectively. The eluates of wild-type and of the mu-
tants gave a major band with a Mr of about 59 kDa on SDS-
PAGE. Their TH speci¢c activities for the conversion of L-
tyrosine to L-dopa were about 600 nmol/min/mg of protein in
the assay bu¡er (pH 7.7) containing 0.2 mM L-tyrosine and
1 mM 6RBPH4.
3.3. Inhibition by dopamine
The pH activity pro¢les of wild-type and four mutants were
examined by use of the assay bu¡ers with various pHs of 6.2,
6.7, 7.2, 7.7, 8.2 and 8.7 (Fig. 2: horizontal abscissa are plot-
ted according to the actual pH values of the assay mixtures).
The maximal activity of the wild-type enzyme was observed
over a broad basic range. Preincubation of the wild-type with
1, 10 or 100 WM dopamine lowered the catalytic activity meas-
ured in the basic pH range. However, the strong inhibitory
e¡ect of dopamine on the catalytic activity was not observed
in the acidic pH range for either wild-type or any mutants.
Replacement of Arg at positions 37 and 38 by Gly reduced
the inhibitory e¡ect of dopamine on the catalytic activity
measured in the basic pH range. For the mutants RR-RG
and RR-GR, 100 WM dopamine inhibited the catalytic activ-
ities more strongly than 1 or 10 WM dopamine. Dopamine at
1 or 10 WM failed in inhibiting su⁄ciently the catalytic activity
of RR-GG. For the mutant RR-EE, in which Arg was re-
placed by Glu, neither 1 nor 10 WM dopamine inhibited the
catalytic activities. Collectively, the inhibitory e¡ect of dopa-
mine depended on the charge of amino acids at positions 37
and 38.
3.4. CD spectrum
Although slight di¡erences in the overall signal strength of
the CD spectra were observed among wild-type and the four
mutants, the overall shapes of the CD spectra were not di¡er-
ent from each other (data not shown).
4. Discussion
We recently reported that Arg37-Arg38 within the N-termi-
nus was a key sequence for the inhibitory e¡ect of dopamine
[5,6]. To clarify why the Arg37-Arg38 sequence is so de¢nitive
in the dopamine inhibition, we thought that information on
the tertiary structure of the N-terminus should be applied.
However, there has been no information concerning the ter-
tiary structure of N-terminus, because the crystallization of
the TH molecule had been performed with rat TH having
up to 155 amino acid residues deleted from the N-terminus
[28,29]. Therefore, to rationalize the critical role of Arg37-
Arg38, we predicted the secondary structure of residues 1^60
of the N-terminus of hTH1 with the assistance of computer
software. All the predictions performed in this research con-
verged to give the following secondary structure: the ¢rst K-
helix (K-helix 1, around residues 16^29) and the second K-
helix (K-helix 2, around residues 42^59) are connected by a
turn (around residues 30^41) (Fig. 1). The amino acid residues
Arg37-Arg38 highlighted in this study are located in the turn
connecting the two helices. It is noteworthy that the catalytic
activity of hTH1 having no less than 29 amino acid residues
of its N-terminus deleted was reduced to 20% of that of the
wild-type enzyme [6]. The presence of K-helix 1 thus appears
to be fundamental to maintain the catalytic activity of the
enzyme.
It has been suggested that the characters of the amino acid
residues residing in the N-terminus of TH a¡ect the catalytic
activity. Birman et al. reported that the group of negative
charges formed in the N-terminus of Drosophila TH type II
had the same e¡ect on catalytic activity as that of certain
polyanions such as heparin [30]. According to this line of
evidence, we focused on the positive charges of Arg37-Arg38
in the N-terminus of hTH1. We produced the hTH1 mutants
in which Arg37-Arg38 was replaced by Gly and/or Glu to
modulate their electrical charges. Each mutant eluted at a
Fig. 2. E¡ect of preincubation with dopamine on the catalytic activ-
ity of the enzymes. The representative plots obtained from wild-type
hTH1 and the four mutants are displayed in the panels. The assay
conditions are described in the text. The ¢nal concentrations of L-ty-
rosine and 6RBPH4 were 0.05 mM and 0.2 mM, respectively. Each
point in the ¢gures is expressed as the mean value of duplicate
measurements.
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di¡erent concentration of KCl from heparin-Sepharose almost
in parallel with the intensity of the positive charges intrinsic to
the amino acids at positions 37 and 38. However, the overall
shapes of the CD spectra were not di¡erent among wild-type
and the four mutants in spite of the presence of the slight
di¡erences in the overall signal strength of the CD spectra
from each other. Furthermore, all the mutant enzymes exam-
ined in this study possessed catalytic activity to almost the
same degree as the wild-type enzyme when assayed in the
dopamine-free condition. These results suggest that the muta-
tions did not cause any signi¢cant collapse of the tertiary
structure. The maintenance of catalytic activity of the mutants
also indicates that the positive charge Arg37-Arg38 is not so
powerful to determine the overall conformation of the hTH1
molecule.
Next, we examined the e⁄ciency of dopamine-mediated in-
hibition of the catalytic activities of these mutants. It is al-
ready known that the dopamine-mediated inhibition is caused
by the formation of charge-transfer complex following the
binding of dopamine to the active site iron located in the C-
terminal two-thirds of the enzyme [31^36]. As was expected
from our previous reports [5,6], our data in this research in-
dicate that the positive charge of the amino acid residues at
positions 37 and 38 is deeply involved in determining the
e⁄cacy of the dopamine-induced inhibition of the catalytic
activity (Fig. 2). Again, the inhibitory e¡ect of dopamine on
the catalytic activity was pH-dependent for either wild-type or
any mutants, which was coincided well with the previous re-
port by Haavik et al. [37]. It is noteworthy that among the
amino acid residues in the turn, Arg37-Arg38 are the only ones
that are electrically charged. It would thus be reasonable to
speculate that the mutations of Arg37 and/or Arg38 to the
neutral and/or negatively charged amino acids would cause
some structural change in the turn. Although the overall
shapes of the CD spectra were not di¡erent among wild-
type and the mutants, the possibility of local structural
changes induced by the mutations cannot be absolutely de-
nied, because not huge but suggestive di¡erences in the overall
signal strength of the CD spectra were observed among them.
It has been suggested that the TH enzyme inactivated by
the binding of dopamine can be reactivated by the phosphor-
ylation of Ser residues in the N-terminus, which might expel
dopamine from the TH molecule. The series of events should
be one of the most important mechanisms to regulate the
catalytic activity of the enzyme in vivo [4]. In spite of the
presence of three phosphorylation sites in the N-terminus of
hTH1, i.e. Ser19, Ser31 and Ser40 [38], the fact that only Ser31
and Ser40 are readily phosphorylated to activate hTH1 in
vitro has become a general consensus [7,8,39]. In this study,
we indicated that Ser31 and Ser40 are located within the turn
along with Arg37-Arg38 (Fig. 1), which suggests that the Ser
residues located near Arg37-Arg38 can enhance the catalytic
activity of the enzyme by their phosphorylation. Therefore,
the positive charge intrinsic to Arg37-Arg38 should largely
contribute to maintain the characteristic of the turn and, as
a result, control the e⁄ciency of dopamine binding to (or
dopamine expelling from) the enzyme. A theory that can ex-
plain the interrelationship among the positive charge of the
speci¢ed amino acid residues, phosphorylation of Ser residues,
and dopamine binding (or dopamine expelling) still remains to
be constructed.
In conclusion, this is the ¢rst report to specify the impor-
tance of the positive charge of Arg37-Arg38 in determining the
e⁄ciency of the dopamine inhibition from the perspective of
the tertiary structure of the N-terminus 1^60 amino acid re-
gion of hTH1.
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